Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot randomized double-blinded split-face study of trifarotene vs adapalene in mild to moderate acne vulgaris
TCTR20260127006Phase 4Not yet recruiting
- Sponsor
- St John's Institute of Dermatology
- Start
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of trifarotene, adapalene in acne vulgaris, sponsored by St John's Institute of Dermatology. Planned start Jan 2026; status: not yet recruiting.
02
Drugs
trifaroteneadapalene
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on TCTR20260127006.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20260127006.